Dyadic International Inc. (DYAI) Live Share Price, Invest From India

Dyadic International Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's High
$0.78
Day's Price Range
$0.89
$0.78
14.10%
Upside
52 Week's Low
52 Week's High
$0.65
52-Week Price Range
$1.35
$0.78
16.08%
Downside
72.56%
Upside

Dyadic International Inc. share price movements today

Previous Close: $0.85
Open: $0.85
Volume: 668.3K
Day's Low - High: $0.78 - $0.89
52 Week Low - High: $0.65 - $1.35

Dyadic International Inc. Historical Returns

1 Month Return: + 8.46 %
3 Month Return: -2.04 %
1 Year Return: -21.01 %
3 Year Return: -64.45 %
5 Year Return: -76.66 %

Dyadic International Inc. Stock Fundamentals & Key Indicators

Check Dyadic International Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$30.9M

EPS (TTM)

-0.0967

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

3.8M

Profit Margin

-191.50%

Return On Equity TTM

-2826.92%

Dyadic International Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dyadic International Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Dyadic International Inc.	BUY	$30.9M	-76.66%	NA	-191.50%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Dyadic International Inc. Stock including INR - Dollar returns

The Dyadic International Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Dyadic International Inc. investment value today

Current value as on today

₹85,565

Returns

-₹14,435

(-14.44%)

Returns from Dyadic International Inc. Stock

-₹21,212 (-21.21%)

Dollar Impact

₹6,777 (+6.78%)

Analyst Recommendation on Dyadic International Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Dyadic International Inc.. Average target price of $6

Dyadic International Inc. Share Price Target

Get share price movements and forecasts by analysts on Dyadic International Inc..

What analysts predicted

87%UPSIDE

Target Price

Current Price

$0.78

Analyzed by

7 Analysts

Target

$6.00

Dyadic International Inc. target price $6, a slight upside of 87% compared to current price of $0.78. According to 7 analysts rating.

Indian Investors' Interest in Dyadic International Inc. Stock

Search interest for Dyadic International Inc. Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 20, 2026 to June 19, 2026

Change:6% versus previous 30 day period

Dyadic International Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	1	0	0	0	1	0	1
Gross Profit	0	0	0	1	0	0	0	0	0	0
Operating Income	-2	-2	-2	0	-1	-2	-1	-1	-1	-1
EBITDA	0	-1	-1	0	-1	-1	-1	-1	-1	-1
Interest Expense	1	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-4	-2	-2	0	-1	-2	-1	-1	-1	-1
Income Tax Expense	-2	0	-2	-	0	-	-	-	-	-
Net Income	-2	-2	-2	0	-1	-2	-1	-1	-1	-1
Net Profit Margin	-301.78%	-600.57%	-529.99%	-10.39%	-189.74%	-1107.36%	-387.05%	-169.67%	-664.89%	-175.95%

Dyadic International Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	1	1	1	2	2	2	3	1
Gross Profit	0	0	0	0	0	0	0	0	2	-1
Operating Income	-5	-7	-7	-9	-10	-14	-10	-8	-5	-7
EBITDA	-5	-2	-7	-9	-9	-11	-10	-8	-5	-6
Interest Expense	0	0	0	0	0	0	0	-	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-3	-2	-6	-8	-9	-13	-9	-6	-5	-7
Income Tax Expense	0	0	-1	0	0	0	0	-8	-5	-
Net Income	-3	-2	-5	-8	-9	-13	-9	-6	-5	-7
Net Profit Margin	-608.67%	-281.61%	-439.36%	-494.21%	-582.13%	-543.73%	-332.23%	-234.42%	-166.19%	-597.63%

Dyadic International Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-2	-2	0	-1	-2	-1	-1	-1	-1
Operating Cash Flow	-1	-1	0	0	-1	0	-1	-1	-1
Investing Cash Flow	0	-2	0	1	0	0	0	0	1
Financing Cash Flow	5	-	-	0	0	-	4	0	-
Change in Cash	4	-4	0	0	-1	-1	3	-1	0

Dyadic International Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-5	-8	-9	-13	-9	-6	-5	-7
Operating Cash Flow	-2	-4	-5	-6	-11	-8	-6	-3	-5
Investing Cash Flow	0	3	7	22	5	-2	7	-1	0
Financing Cash Flow	-6	-2	0	0	1	0	-	5	4
Change in Cash	-8	-3	2	15	-4	-9	0	0	0

Global Institutional Holdings in Dyadic International Inc.

Funds	Holdings
State Street Corp	0.12%
Northern Trust Corp	0.09%
Northeast Financial Consultants, Inc	0.69%
Vanguard Group Inc	2.51%
Robertson Stephens Wealth Management, LLC	0.08%

See all

Insights on Dyadic International Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 235.71K → 1.11M (in $), with an average increase of 78.8% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, DYAI stock has moved up by 14.7%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.8% return, outperforming this stock by 39.8%
NO EFFECT
Against Peers
In the last 3 years, Dyadic International, Inc. Common Stock has experienced a drawdown of -64.5%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 42.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -1.56M → -1.95M (in $), with an average decrease of 24.7% per quarter

About Dyadic International Inc.

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Organisation	Dyadic International Inc.
Headquarters	1044 North U.S. Highway One, Jupiter, FL, United States, 33477-5094
Industry	Biotechnology
CEO	Mr. Mark A. Emalfarb
E-voting on shares	Click here to vote

Key Management of Dyadic International Inc.

Name	Title
Mr. Mark A. Emalfarb	Founder, CEO & Director
Mr. Joseph P. Hazelton	President & COO
Ms. Ping Wang Rawson CPA, M.B.A.	Chief Financial Officer
Ms. Ana Gómez Rodriguez	Secretary of the Board

FAQs

What is Dyadic International Inc. share price today?

Dyadic International Inc. share price today is $0.78 as on June 19, 2026 at 8:45 am IST at the close of the market. Dyadic International Inc. share today touched a day high of $0.89 and a low of $0.78.

What is the 52 week high and 52 week low for Dyadic International Inc. share?

Dyadic International Inc. share touched a 52 week high of $1.35 on October 1, 2025 and a 52 week low of $0.65 on March 26, 2026. Dyadic International Inc. stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $0.78,which is 42.05% down from its 52 week high and 19.16% up from its 52 week low.

What is Dyadic International Inc.'s market capitalisation today?

Dyadic International Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Dyadic International Inc. Stock (DYAI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Dyadic International Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dyadic International Inc. Shares that will get you 1.9231 shares as per Dyadic International Inc. share price of $0.78 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Dyadic International Inc. Stock (DYAI) from India?

Indian investors can start investing in Dyadic International Inc. (DYAI) shares with as little as ₹94.31 or $1 (as of June 19, 2026 at 8:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Dyadic International Inc. stock (as per the Rupee-Dollar exchange rate as on June 19, 2026 at 8:42 pm IST). Based on Dyadic International Inc. share’s latest price of $0.78 as on June 19, 2026 at 8:45 am IST, you will get 12.8205 shares of Dyadic International Inc.. Learn more about fractional shares .

What are the returns that Dyadic International Inc. has given to Indian investors in the last 5 years?

Dyadic International Inc. stock has given -76.66% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?